SEATTLE, March 26, 2020 /PRNewswire/ -- According to
Coherent Market Insights, global viral vector and plasmid DNA
testing services market was valued at US$
76.4 million in 2018 and is expected to exhibit a CAGR of
25.0% over the forecast period (2019-2027).
Key Trends and Analysis of the Global Viral Vector and
Plasmid DNA Testing Services Market:
Key trends in the market include rising acquisitions in the
global viral vector and plasmid DNA testing services market by
players, which is expected to propel the market growth over the
forecast period. For instance, in 2017, Eurofins acquired
Villapharma Research SL in Spain
to expand its portfolio of services into comprehensive
offering and further strengthen its service proposition for the
pharma and biotech industries. Moreover, various mergers,
partnerships, and collaborations by key players are expected to
propel the market growth.
Request for Sample PDF copy @
https://www.coherentmarketinsights.com/insight/request-sample/3637
For instance, in September 2018,
Charles River Laboratories, Inc. and PathoQuest announced the
expansion of partnership, in order to offer next-generation
sequencing (NGS) services to biopharmaceutical companies Moreover,
in September 2018, Charles River
Laboratories, Inc. and PathoQuest expanded their partnership, in
order to offer next-generation sequencing (NGS) services to
biopharmaceutical companies.
However, high cost of testing services such as safety, potency
and others are expected to restrain the market growth over the
forecast period. For instance, according to VIROVEK, a company
offering quality control assays for the Adeno-associated virus
(AAV) products costs US$ 2,500 to
perform multiplicity of infection (MOI) optimization for the first
sample and additional sample costs US $
2,500/per additional sample.
Key Market Takeaways:
- The global viral vector and plasmid DNA testing services market
is expected to exhibit a CAGR of 25.0% over the forecast period
(2019-2027) due to favorable regulatory scenario for better gene
therapies solution by the government authorities. For instance, in
January 2020, the U.S. Food and Drug
Administration (FDA) issued 6 new guidelines for gene therapy on
manufacturing and clinical development of gene therapy products to
avoid the similar characteristics of viral vector and plasmid DNA
products.
- Key players in the market are focused on partnerships for the
development of drugs innovated with the viral vector or plasmid
DNA, which is expected to propel the market growth over the
forecast period. For instance, in August
2017, Takara Bio Inc. entered into a partnership with Osaka
University Hospital for the project of cancer genome medicine. The
Osaka University Hospital lab was established to perform cancer
genetic testing services.
Key players operating in the global viral vector and plasmid
DNA testing services market include—
Charles River Laboratories, Inc., WuXi AppTec Co., Ltd., Cobra
Biologics and Pharmaceutical Services, Merck KGaA, Lonza, Eurofins
Scientific, FinVector Vision Therapies, Advanced Bioscience
Laboratories, Inc., Takara Bio Inc., ViruSure GmbH, and Genezen
Laboratories
Buy this Report Now @
https://www.coherentmarketinsights.com/insight/buy-now/3637
Market Segmentations:
- Global viral vector and plasmid DNA testing services market,
by testing services:
-
- Safety
- Genetic Characterization
- Purity
- Identity
- Potency
- Global viral vector and plasmid DNA testing services market,
By end user:
-
- Research Organizations
- Pharmaceutical and Biotechnological Companies
- Global viral vector and plasmid DNA testing services market,
By Region:
-
- North America
-
- Latin America
-
- By Country:
-
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
-
- By Country:
-
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
-
- By Country:
-
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Pakistan
- Rest of Asia Pacific
- Middle East
-
- By Country:
-
- GCC
- Israel
- Rest of Middle East
- Africa
-
- By Country/Region:
-
- North Africa
- Central Africa
- South Africa
Did not find what you were looking for? Here are some similar
Topics:
LIFESCIENCE REAGENT MARKET
Lifescience reagent is an important component, especially in
biotechnology industry for identification and analysis of the
biological materials. There are different type of reagents such as
diagnostic reagents, biochemical reagents, genomic reagents and
others, and are available in the market for various research
purposes. Diagnostics reagents play an important role in the
medical labs to produce test results for various diagnostics and
biological samples through various testing assays.
Read more @
https://www.coherentmarketinsights.com/market-insight/lifescience-reagent-market-2681
ELECTROPHORESIS MARKET
Increasing research and development activities in the field of
proteomics, genomics, and drug discovery is the major factor
driving the global electrophoresis market growth. Increasing
research in genomics and rising initiatives, investments, grants,
and funds by government in the field genomics is creating growth
opportunities for industry players. For instance, in 2016, National
Human Genome Research Institute launched a new initiative Genes,
Environment and Health Initiative (GEI) to support the research
that lead to the understanding of genetic contribution and their
effect in common diseases.
Read more @
https://www.coherentmarketinsights.com/market-insight/electrophoresis-market-2666
BACTERIOPHAGES THERAPY MARKET
Increasing prevalence of drug resistant infections is expected
to drive demand for bacteriophage therapy to overcome outbreak of
infection. For instance, as per the Centers for Disease Control and
Prevention (CDC), in February 2019,
around 129 people from 32 U.S. states were infected with the
outbreak strain of Salmonella Infantis. Moreover, the CDC also
conducted antibiotic resistance testing on Salmonella bacteria
isolated from infected patients.
Read more @
https://www.coherentmarketinsights.com/market-insight/bacteriophages-therapy-market-2752
Contact Us:
Mr. Raj Shah
Coherent Market Insights
1001 4th Ave.
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
View original
content:http://www.prnewswire.com/news-releases/global-viral-vector-and-plasmid-dna-testing-services-market-to-surpass-us-565-3-million-by-2027--says-cmi-301030280.html
SOURCE Coherent Market Insights